Literature DB >> 29563169

Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer.

Jon Zugazagoitia1,2,3,4, Mercedes Biosca5, Julio Oliveira6, María Eugenia Olmedo7, Manuel Dómine8, Ernest Nadal9,10, José Carlos Ruffinelli9, Nerea Muñoz1, Ana María Luna11, Berta Hernández12, Maite Martínez12, Iria Gallego13, Eva Martínez de Castro14, Carme Font15, Virginia Calvo16, Virginia Martínez-Marín17, Jesús Corral18, Esther Noguerón19, Rebeca Mondéjar20, Ignacio García Escobar21, Carmen Salvador-Coloma22, Óscar Juan22, Manuel Sánchez Cánovas23, Javier Valdivia24, M Pilar Ochoa25, Rafael López Castro26, Berta Obispo27, Cristina Pangua27, María Sereno28, Lourdes Fernández Franco29, Xabier Mielgo30, Julia Calzas31, Ana Blasco32, Francisco Aparisi33, Luis Chara34, Juan Francisco Grau5, Marta Soares6, Ana Gómez7, Victor Zenzola8, Marcial García-Morillo15, Diego Cacho14, Asunción Díaz-Serrano1,2, Carlos Aguado11, Santiago Ponce-Aix1,2, Jose Luis González-Larriba11, Andrés J Muñoz13, David Lora35, Luis Paz-Ares1,2,3, Aránzazu Manzano11,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29563169     DOI： 10.1183/13993003.02431-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  8 in total

1.  SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019).

Authors:  A J Muñoz Martín; E Gallardo Díaz; I García Escobar; R Macías Montero; V Martínez-Marín; V Pachón Olmos; P Pérez Segura; T Quintanar Verdúguez; M Salgado Fernández
Journal:  Clin Transl Oncol       Date:  2020-01-24       Impact factor: 3.405

Review 2.  Thrombotic complications in patients with cancer: Advances in pathogenesis, prevention, and treatment-A report from ICTHIC 2021.

Authors:  Anna Falanga; Benjamin Brenner; Alok A Khorana; Charles W Francis
Journal:  Res Pract Thromb Haemost       Date:  2022-07-01

3.  Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients.

Authors:  Federico Nichetti; Francesca Ligorio; Emma Zattarin; Diego Signorelli; Arsela Prelaj; Claudia Proto; Giulia Galli; Antonio Marra; Giulia Apollonio; Luca Porcu; Filippo de Braud; Giuseppe Lo Russo; Roberto Ferrara; Marina Chiara Garassino
Journal:  Cancers (Basel)       Date:  2019-12-25       Impact factor: 6.639

4.  Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Authors:  Xiaohan Qian; Mengjiao Fu; Jing Zheng; Jianya Zhou; Jianying Zhou
Journal:  Front Oncol       Date:  2021-04-29       Impact factor: 6.244

5.  Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients.

Authors:  Cecilia Becattini; Melina Verso; Andres Muňoz; Giancarlo Agnelli
Journal:  Haematologica       Date:  2019-06-06       Impact factor: 9.941

6.  High discrepancy in thrombotic events in non-small cell lung cancer patients with different genomic alterations.

Authors:  Yiwei Liu; Wanying Wang; Fengying Wu; Guanghui Gao; Jian Xu; Xuefei Li; Chao Zhao; Shuo Yang; Shiqi Mao; Yingying Pan; Keyi Jia; Chuchu Shao; Bin Chen; Shengxiang Ren; Caicun Zhou
Journal:  Transl Lung Cancer Res       Date:  2021-03

7.  Acquired G2032R Resistance Mutation in ROS1 to Lorlatinib Therapy Detected with Liquid Biopsy.

Authors:  Balázs Jóri; Markus Falk; Iris Hövel; Peggy Weist; Markus Tiemann; Lukas C Heukamp; Frank Griesinger
Journal:  Curr Oncol       Date:  2022-09-16       Impact factor: 3.109

8.  The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China.

Authors:  Jiawen Yi; Huang Chen; Jie Li; Xingran Jiang; Yan Xu; Mengzhao Wang; Zheng Wang; Zhenguo Zhai; Yanhong Ren; Yuhui Zhang
Journal:  Thromb J       Date:  2022-09-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.